Provided by Tiger Trade Technology Pte. Ltd.

Atai Beckley Inc

7.29
+0.01000.14%
Pre-market: 7.310.0195+0.27%06:00 EDT
Volume:14.86M
Turnover:108.53M
Market Cap:2.70B
PE:-3.41
High:7.33
Open:7.32
Low:7.28
Close:7.28
52wk High:7.45
52wk Low:3.27
Shares:369.95M
Float Shares:294.14M
Volume Ratio:0.45
T/O Rate:5.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1359
EPS(LYR):-2.9137
ROE:-417.21%
ROA:-39.03%
PB:15.29
PE(LYR):-2.50

Loading ...

Lilly to Buy Atai Beckley for USD 6.75 a Share Plus CVR up to USD 2.5

Reuters
·
Jul 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 16

Eli Lilly Says Clinical Trial Success Propels Ataibeckley Lead Program into Phase 3

Dow Jones
·
Jul 16

Premarket Movers | Atai Beckley Gives Up Most Gains, Up 30% After Surging 70%

Tiger Newspress
·
Jul 16

Lilly to Acquire Ataibeckley to Advance Therapies for Treatment-resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Jul 16

Ataibeckley Surges After Report Says Lilly is Nearing Buyout Deal

Reuters
·
Jul 16

Premarkt Movers | ATAI Soars 42%; JBHT Jumps 8%; UAL Drops 2%; TSM Drops 3%; ASTS Drops 11%

Tiger Newspress
·
Jul 16

Ataibeckley Shares Jump 42.2% Premarket After Report Eli Lilly Nears Deal to Buy Co

THOMSON REUTERS
·
Jul 16

U.S. Research Roundup- Blackrock, Goldman Sachs, Synopsys

Reuters
·
Jul 16

AtaiBeckley (ATAI) Stock Skyrockets 65% After-Hours on Reported Eli Lilly Acquisition Talks

Benzinga_recent_news
·
Jul 16

24H | Ataibeckley Soars 56%. Eli Lilly Nears Deal to Buy Psychedelic Drugmaker Ataibeckley

Reuters
·
Jul 16

Major Pharma Giant Reportedly in Talks for Premium Acquisition of Psychedelics Firm

Stock News
·
Jul 16

Eli Lilly Nears Agreement to Acquire Psychedelic Drug Developer Atai Beckley

Deep News
·
Jul 16

AtaiBeckley jumps 55% after report of Eli Lilly takeover interest

TIPRANKS
·
Jul 16

Lilly Said to Near Deal for Psychedelic Drugmaker Ataibeckley- Bloomberg News

THOMSON REUTERS
·
Jul 16

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 15

Atai Beckley Director Robert Hershberg Disposes of Common Shares Worth $496,000

Reuters
·
Jul 10

ATAI Life Sciences is Maintained at Buy by Jefferies

Dow Jones
·
Jul 06

AtaiBeckley rumor highlighted in Betaville blog

TIPRANKS
·
Jul 06

AtaiBeckley Concludes Patient Dosing In Phase 2b Treatment-Resistant Depression Trial

MT Newswires Live
·
Jul 06